The State of State Biomarker Testing Insurance Coverage Laws

JAMA. 2024 May 13. doi: 10.1001/jama.2024.6058. Online ahead of print.

Authors

Grace A Lin^{1

2}, Janet M Coffman², Kathryn A Phillips^{1

2}

Affiliations

¹ Center for Translational and Policy Research on Precision Medicine (TRANSPERS), Department of Clinical Pharmacy, University of California, San Francisco.
² Institute for Health Policy Studies, University of California, San Francisco.

PMID: 38739406
DOI: 10.1001/jama.2024.6058

No abstract available

Plain language summary

This Viewpoint discusses laws mandating insurance coverage of biomarker testing to broaden access to care for patients with cancer.